Systemic treatment with water-soluble corticosteroid phosphates

Pruritus ani - Systemic treatment with water-soluble corticosteroid phosphates Factor

Last reviewed for CCPS 30 June 1999.

Preliminary questions [16842]

17082 there is some evidence that systemic treatment with water soluble corticosteroid phosphates may be a factor in the development or worsening of the condition under consideration.

17027 the veteran has been systemically treated with water-soluble corticosteroid phosphates at some time.

17029 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and VEA service for pruritus ani.

17032 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and VEA service for the clinical onset of pruritus ani.

17034 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and operational service for the clinical onset of pruritus ani.

or

17035 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and eligible service for the clinical onset of pruritus ani.

or

16849 the clinical onset of the veteran's pruritus ani occurred after the end of the veteran's last period of VEA service.

16850

the veteran's pruritus ani permanently worsened.

17031

for the identified illness or injury, the veteran was being systemically treated with water-soluble corticosteroid phosphates within the 24 hours immediately before the clinical worsening of the condition under consideration.

17033 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and VEA service for the clinical worsening of pruritus ani.

17036 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and operational service for the clinical worsening of pruritus ani.

or

17037 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and eligible service for the clinical worsening of pruritus ani.

Clinical onset and operational service [17034]

26806

on operational service, the veteran was being systemically treated with water-soluble corticosteroid phosphates.

26807

on operational service, the veteran was being systemically treated with water-soluble corticosteroid phosphates within the 24 hours immediately before the clinical onset of the condition under consideration.

26808

the systemic treatment with water-soluble corticosteroid phosphates, on operational service, within the 24 hours immediately before the clinical onset of the condition under consideration, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

17028

the veteran was systemically treated with water-soluble corticosteroid phosphates for an illness or injury which is identifiable.

17030

for the identified illness or injury, the veteran was being systemically treated with water-soluble corticosteroid phosphates within the 24 hours immediately before the clinical onset of the condition under consideration.

17038 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to operational service.

Clinical onset and eligible service [17035]

17028

the veteran was systemically treated with water-soluble corticosteroid phosphates for an illness or injury which is identifiable.

17030

for the identified illness or injury, the veteran was being systemically treated with water-soluble corticosteroid phosphates within the 24 hours immediately before the clinical onset of the condition under consideration.

17039 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to eligible service.

Clinical worsening and operational service [17036]

17038 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to operational service.

17040

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related.

Clinical worsening and eligible service [17037]

17039 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to eligible service.

17041

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related.